Inte:Ligand
Inte:Ligand was founded in Maria Enzersdorf, Lower Austria (Niederösterreich) in 2003. They established the company headquarters on Mariahilferstrasse in Vienna, Austria that same year. In 2007 Inte:Ligand was the recipient of the NÖ Innovation prize (Innovationpreis) for the development of the simulation software LigandScout. As of 2017 there were more than 1500 literature, book chapters and review articles published related to InteLigand software technology in the areas of virtual screening, 3D-pharmacophore modeling, hit identification, medicinal chemistry decision support, activity profiling, docking, fragment-based compound design, protein-protein-interactions, drug-repurposing and molecular dynamics simulations. Other  applications include the discovery of new Myeloperoxidase ligands, HIV reverse transcriptase inhibitors, applications in anti-viral bio-activity profiling, the development of models to predict HIV Protease activity, Cytochrome P450 activity prediction and simulation models for the activity on Factor Xa. See also. Other companies and institutions providing drug discovery software: